Información de la revista
Original article
Acceso a texto completo
ACSL1: A preliminary study that provides a new target for the treatment of renal fibrosis could bring new insights in diabetic kidney disease
ACSL1: un estudio preliminar que aporta un nuevo objetivo para el tratamiento de la fibrosis renal podría proporcionar una nueva percepción en la nefropatía diabética
Zhonghui Caoa,b,1, Xiao Gaoa,1, Jing Menga,1, Xiaoli Guoa,1, Jiahao Xua,1, Junchao Cuia,1, Xueyan Zhoua,1,
Autor para correspondencia
zxy851107@xzhmu.edu.cn

Corresponding author.
a Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, College of Pharmacy, Xuzhou Medical University, Xuzhou 221004, China
b Department of Pharmacy, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221004, China

Artículo

This article is available in English

ACSL1: A preliminary study that provides a new target for the treatment of renal fibrosis could bring new insights in diabetic kidney disease

Zhonghui Cao, Xiao Gao, Jing Meng, Xiaoli Guo, Jiahao Xu, Junchao Cui, Xueyan Zhou
10.1016/j.nefroe.2023.05.008
Nefrologia (English Version). 2023;43 Supl 2:38-46
Idiomas
Nefrología